Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
c ebpβ-lip drug

c ebpβ-lip drug C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP beta Antibody | Cell

C EBP beta Antibody Cell Signaling Technology A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports A) Domain organization of C EBP family members. Each C EBP protein Download Scientific Diagram C EBP: The structure, regulation, and its roles in inflammation related diseases ScienceDirect C EBP LIP induces cancer type metabolic reprogramming by regulating the let 7 LIN28B circuit in mice Communications Biology

SKU: 46611781141 · From vanierexcavation.com

4.9
USD24.22 USD69.22

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

No metabolic tax

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP beta Antibody | Cell

Aortic pulse wave velocity as a measure of cardiovascular risk in chronic obstructive pulmonary disease: two-year follow-up data from the ARCADE study

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP beta Antibody | Cell

[DOI] [PMC free article] [PubMed] [Google Scholar] 997.Pacher P, Szabo C

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP beta Antibody | Cell

May Help Reduce Oxidative Stress Oxidative stress is a natural process that contributes to cellular aging over time

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP beta Antibody | Cell

and Hagiwara, H

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module C/EBP beta Antibody | Cell
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products